Phosphatidylinositol-3,4,5-trisphosphate: Tool of choice for class I PI 3-kinases

BioEssays

Volumn 35, Issue 7, 2013, Pages 602-611

  Salamon, Rachel Schnur ^a   Backer, Jonathan M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

PH domain; Phosphoinositides; PI 3 kinase; Signal transduction

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LIPID BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN SH3;

ALLOSTERISM; ARTICLE; CELL CULTURE; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME BINDING; ENZYME KINETICS; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PROLINE RICH PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CLASS I PHOSPHATIDYLINOSITOL 3-KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MODELS, ANIMAL; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTEIN INTERACTION DOMAINS AND MOTIFS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84879184496     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200176     Document Type: Article

References (120)

1. Backer JM. 2010. The regulation of class IA PI 3-kinases by inter-subunit interactions. Curr Top Microbiol Immunol 346: 87-114.
2. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. 2010. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11: 329-41.
3. Auger KR, Serunian LA, Soltoff SP, Libby P, et al. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167-75.
4. Serunian LA, Auger KR, Cantley LC. 1991. Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol 198: 78-87.
5. van der Kaay J, Batty IH, Cross DA, Watt PW, et al. 1997. A novel, rapid, and highly sensitive mass assay for phosphatidylinositol 3, 4, 5-trisphosphate (PtdIns(3, 4, 5)P3) and its application to measure insulin-stimulated PtdIns(3, 4, 5)P3 production in rat skeletal muscle in vivo. J Biol Chem 272: 5477-81.
6. Dowler S, Kular G, Alessi DR. 2002. Protein lipid overlay assay. Sci STKE 2002: pl6.
7. Clark J, Anderson KE, Juvin V, Smith TS, et al. 2011. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods 8: 267-72.
8. Serunian LA, Haber MT, Fukui T, Kim JW, et al. 1989. Polyphosphoinositides produced by phosphatidylinositol 3-kinase are poor substrates for phospholipase C from rat liver and bovine brain. J Biol Chem 264: 17809-15.
9. Lemmon MA. 2008. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 9: 99-111.
10. Stam JC, Collard JG. 1999. The DH protein family, exchange factors for Rho-like GTPases. Prog Mol Subcell Biol 22: 51-83.
11. Erickson JW, Cerione RA. 2004. Structural elements, mechanism, and evolutionary convergence of Rho protein-guanine nucleotide exchange factor complexes. Biochemistry 43: 837-42.
12. Pearce LR, Komander D, Alessi DR. 2010. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11: 9-22.
13. Varnai P, Bondeva T, Tamas P, Toth B, et al. 2005. Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3, 4, 5)P3 suggest their interaction with protein binding partners. J Cell Sci 118: 4879-88.
14. Campa F, Yoon HY, Ha VL, Szentpetery Z, et al. 2009. A PH domain in the Arf GTPase-activating protein (GAP) ARAP1 binds phosphatidylinositol 3, 4, 5-trisphosphate and regulates Arf GAP activity independently of recruitment to the plasma membranes. J Biol Chem 284: 28069-83.
15. Fayard E, Xue G, Parcellier A, Bozulic L, et al. 2010. Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr Top Microbiol Immunol 346: 31-56.
16. Mizuno-Yamasaki E, Rivera-Molina F, Novick P. 2012. GTPase networks in membrane traffic. Annu Rev Biochem 81: 637-59.
17. Felices M, Falk M, Kosaka Y, Berg LJ. 2007. Tec kinases in T cell and mast cell signaling. Adv Immunol 93: 145-84.
18. Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-19.
19. Stephens L, Hawkins P. 2011. Signalling via class IA PI3Ks. Adv Enzyme Regul 51: 27-36.
20. Miled N, Yan Y, Hon WC, Perisic O, et al. 2007. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317: 239-42.
21. Mandelker D, Gabelli SB, Schmidt-Kittler O, Zhu J, et al. 2009. A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. Proc Natl Acad Sci USA 106: 16996-7001.
22. Zhang X, Vadas O, Perisic O, Anderson KE, et al. 2011. Structure of lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol Cell 41: 567-78.
23. Yu JH, Wjasow C, Backer JM. 1998. Regulation of the p85/p110α phosphatidylinositol 3′-kinase - Distinct roles for the N-terminal and C-terminal SH2 domains. J Biol Chem 273: 30199-203.
24. Burke JE, Vadas O, Berndt A, Finegan T, et al. 2011. Dynamics of the phosphoinositide 3-kinase p110delta interaction with p85alpha and membranes reveals aspects of regulation distinct from p110alpha. Structure 19: 1127-37.
25. Klippel A, Reinhard C, Kavanaugh WM, Apell G, et al. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol 16: 4117-27.
26. Burke JE, Perisic O, Masson GR, Vadas O, et al. 2012. Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110alpha (PIK3CA). Proc Natl Acad Sci USA 109: 15259-64.
27. Dbouk HA, Vadas O, Shymanets A, Burke JE, et al. 2012. G Protein-coupled receptor-mediated activation of p110beta by Gbetagamma is required for cellular transformation and invasiveness. Sci Signal 5: ra89.
28. Maier U, Babich A, Nürnberg B. 1999. Roles of non-catalytic subunits in Gβgamma-induced activation of class I phosphoinositide 3-kinase isoforms β and gamma. J Biol Chem 274: 29311-7.
29. Brock C, Schaefer M, Reusch HP, Czupalla C, et al. 2003. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J Cell Biol 160: 89-99.
30. Castellano E, Downward J. 2011. RAS interaction with PI3K: More than just another effector pathway. Genes Cancer 2: 261-74.
31. Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, et al. 2000. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103: 931-43.
32. Kurig B, Shymanets A, Bohnacker T, Prajwal, et al. 2009. Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma. Proc Natl Acad Sci USA 106: 20312-7.
33. Zheng Y, Bagrodia S, Cerione RA. 1994. Activation of phosphoinositide 3-kinase by Cdc42Hs binding to p85. J Biol Chem 269: 18727-30.
34. Pleiman CM, Hertz WM, Cambier JC. 1994. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263: 1609-12.
35. Samuels Y, Wang Z, Bardelli A, Silliman N, et al. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
36. Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhari S, et al. 2009. Somatic mutations in p85α promote tumorigenesis through class IA PI3K activation. Cancer Cell 16: 463-474.
37. Parsons DW, Jones S, Zhang X, Lin JC, et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-12.
38. Philp AJ, Campbell IG, Leet C, Vincan E, et al. 2001. The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61: 7426-9.
39. Wu H, Shekar SC, Flinn RJ, El-Sibai M, et al. 2009. Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Proc Natl Acad Sci USA 106: 20258-63.
40. Keniry M, Parsons R. 2008. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27: 5477-85.
41. Song MS, Salmena L, Pandolfi PP. 2012. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-96.
42. Yip SC, Eddy RJ, Branch AM, Pang H, et al. 2008. Quantification of PtdIns(3, 4, 5)P(3) dynamics in EGF-stimulated carcinoma cells: a comparison of PH-domain-mediated methods with immunological methods. Biochem J 411: 441-8.
43. Tengholm A, Meyer T. 2002. A PI3-kinase signaling code for insulin-triggered insertion of glucose transporters into the plasma membrane. Curr Biol 12: 1871-6.
44. Stephens L, Eguinoa A, Corey S, Jackson T, et al. 1993. Receptor stimulated accumulation of phosphatidylinositol (3, 4, 5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J 12: 2265-73.
45. Hawkins PT, Jackson TR, Stephens LR. 1992. Platelet-derived growth factor stimulates synthesis of PtdIns(3, 4, 5)P3 by activating a PtdIns(4, 5)P2 3-OH kinase. Nature 358: 157-9.
46. Kapeller R, Chem KS, Yoakim M, Schaffhausen BS, et al. 1991. Mutations in the juxtamembrane region of the insulin receptor impair activation of phosphatidylinositol 3-kinase by insulin. Mol Endocrinol 5: 769-77.
47. Bohdanowicz M, Cosio G, Backer JM, Grinstein S. 2010. Class I and class III phosphoinositide 3-kinases are required for actin polymerization that propels phagosomes. J Cell Biol 191: 999-1012.
48. Marshall JG, Booth JW, Stambolic V, Mak T, et al. 2001. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J Cell Biol 153: 1369-80.
49. Xu X, Meier-Schellersheim M, Jiao X, Nelson LE, et al. 2005. Quantitative imaging of single live cells reveals spatiotemporal dynamics of multistep signaling events of chemoattractant gradient sensing in Dictyostelium. Mol Biol Cell 16: 676-88.
50. Leslie NR, Dixon MJ, Schenning M, Gray A, et al. 2012. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Enzyme Regul 52: 205-13.
51. Dowler S, Currie RA, Campbell DG, Deak M, et al. 2000. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J 351: 19-31.
52. Manna D, Albanese A, Park WS, Cho W. 2007. Mechanistic basis of differential cellular responses of phosphatidylinositol 3, 4-bisphosphate- and phosphatidylinositol 3, 4, 5-trisphosphate-binding pleckstrin homology domains. J Biol Chem 282: 32093-105.
53. Liu QR, Sasaki T, Kozieradzki I, Wakeham A, et al. 1999. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 13: 786-91.
54. Huber M, Helgason CD, Damen JE, Liu L, et al. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 95: 11330-5.
55. Huang YE, Iijima M, Parent CA, Funamoto S, et al. 2003. Receptor-mediated regulation of PI3Ks confines PI(3, 4, 5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell 14: 1913-22.
56. Ma L, Janetopoulos C, Yang L, Devreotes PN, et al. 2004. Two complementary, local excitation, global inhibition mechanisms acting in parallel can explain the chemoattractant-induced regulation of PI(3, 4, 5)P3 response in dictyostelium cells. Biophys J 87: 3764-74.
57. Iijima M, Devreotes P. 2002. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109: 599-610.
58. Tibarewal P, Zilidis G, Spinelli L, Schurch N, et al. 2012. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci Signal 5: ra18.
59. Davidson L, Maccario H, Perera NM, Yang X, et al. 2010. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene 29: 687-97.
60. Lindsay Y, McCoull D, Davidson L, Leslie NR, et al. 2006. Localization of agonist-sensitive PtdIns(3, 4, 5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 119: 5160-8.
61. Geering B, Cutillas PR, Nock G, Gharbi SI, et al. 2007. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104: 7809-14.
62. Patton DT, Garcon F, Okkenhaug K. 2007. The PI3K p110delta controls T-cell development, differentiation and regulation. Biochem Soc Trans 35: 167-71.
63. Costa C, Martin-Conte EL, Hirsch E. 2011. Phosphoinositide 3-kinase p110gamma in immunity. IUBMB Life 63: 707-13.
64. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, et al. 2006. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: 733-47.
65. Hill K, Welti S, Yu JH, Murray JT, et al. 2000. Specific requirement for the p85-p110α phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J Biol Chem 275: 3741-4.
66. Meier TI, Cook JA, Thomas JE, Radding JA, et al. 2004. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms. Protein Expr Purif 35: 218-24.
67. Beeton CA, Chance EM, Foukas LC, Shepherd PR. 2000. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. Biochem J 350: 353-9.
68. Van Aller GS, Carson JD, Fernandes C, Lehr R, et al. 2008. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay. Anal Biochem 383: 311-5.
69. Suire S, Condliffe AM, Ferguson GJ, Ellson CD, et al. 2006. Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nat Cell Biol 8: 1303-9.
70. Schmid MC, Avraamides CJ, Dippold HC, Franco I, et al. 2011. Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kgamma, a single convergent point promoting tumor inflammation and progression. Cancer Cell 19: 715-27.
71. Yip SC, El-Sibai M, Hill KM, Wu H, et al. 2004. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells. Cell Motil Cytoskeleton 59: 180-8.
72. Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science 327: 46-50.
73. Hope HR, Pike LJ. 1996. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell 7: 843-51.
74. van Rheenen J, Achame EM, Janssen H, Calafat J, et al. 2005. PIP2 signaling in lipid domains: a critical re-evaluation. EMBO J 24: 1664-73.
75. Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, et al. 2007. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell Signal 19: 1081-92.
76. Bjorgo E, Tasken K. 2010. Novel mechanism of signaling by CD28. Immunol Lett 129: 1-6.
77. Calay D, Vind-Kezunovic D, Frankart A, Lambert S, et al. 2010. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes. J Invest Dermatol 130: 1136-45.
78. Gao X, Zhang J. 2008. Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains. Mol Biol Cell 19: 4366-73.
79. Lasserre R, Guo XJ, Conchonaud F, Hamon Y, et al. 2008. Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat Chem Biol 4: 538-47.
80. Chen X, Resh MD. 2002. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 277: 49631-7.
81. Moffett S, Brown DA, Linder ME. 2000. Lipid-dependent targeting of G proteins into rafts. J Biol Chem 275: 2191-8.
82. Wang Y, Pennock SD, Chen X, Kazlauskas A, et al. 2004. Platelet-derived growth factor receptor-mediated signal transduction from endosomes. J Biol Chem 279: 8038-46.
83. Patel HH, Murray F, Insel PA. 2008. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol 186: 167-84.
84. Oh P, Schnitzer JE. 2001. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell 12: 685-98.
85. Foster LJ, De Hoog CL, Mann M. 2003. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100: 5813-8.
86. Lents NH, Irintcheva V, Goel R, Wheeler LW, et al. 2009. The rapid activation of N-Ras by alpha-thrombin in fibroblasts is mediated by the specific G-protein Galphai2-Gbeta1-Ggamma5 and occurs in lipid rafts. Cell Signal 21: 1007-14.
87. Maier U, Babich A, Macrez N, Leopoldt D, et al. 2000. Gbeta 5gamma 2 is a highly selective activator of phospholipid-dependent enzymes. J Biol Chem 275: 13746-54.
88. Roy S, Plowman S, Rotblat B, Prior IA, et al. 2005. Individual palmitoyl residues serve distinct roles in H-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25: 6722-33.
89. Prior IA, Muncke C, Parton RG, Hancock JF. 2003. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 160: 165-70.
90. Rodriguez-Viciana P, Sabatier C, McCormick F. 2004. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24: 4943-54.
91. Vicinanza M, Di Campli A, Polishchuk E, Santoro M, et al. 2011. OCRL controls trafficking through early endosomes via PtdIns4, 5P(2)-dependent regulation of endosomal actin. EMBO J 30: 4970-85.
92. Watt SA, Kular G, Fleming IN, Downes CP, et al. 2002. Subcellular localization of phosphatidylinositol 4, 5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. Biochem J 363: 657-66.
93. Sato M, Ueda Y, Takagi T, Umezawa Y. 2003. Production of PtdInsP3 at endomembranes is triggered by receptor endocytosis. Nat Cell Biol 5: 1016-22.
94. Miaczynska M, Christoforidis S, Giner A, Shevchenko A, et al. 2004. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116: 445-56.
95. Christoforidis S, Miaczynska M, Ashman K, Wilm M, et al. 1999. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol 1: 249-52.
96. Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, et al. 2005. An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170: 607-18.
97. Ciraolo E, Iezzi M, Marone R, Marengo S, et al. 2008. Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 1: ra3.
98. Jia S, Liu Z, Zhang S, Liu P, et al. 2008. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454: 776-9.
99. Bohnacker T, Marone R, Collmann E, Calvez R, et al. 2009. PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3, 4, 5)P3 pools in mast cells. Sci Signal 2: ra27.
100. Kapeller R, Chakrabarti R, Cantley L, Fay F, et al. 1993. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3′ kinase complexes: Potential interactions with the microtubule cytoskeleton. Mol Cell Biol 13: 6052-3.
101. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, et al. 1992. The phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 3469-79.
102. Kelly KL, Ruderman NB. 1993. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem 268: 4391-8.
103. Inoue G, Cheatham B, Emkey R, Kahn CR. 1998. Dynamics of insulin signaling in 3T3-L1 adipocytes - Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J Biol Chem 273: 11548-55.
104. Foukas LC, Claret M, Pearce W, Okkenhaug K, et al. 2006. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441: 366-70.
105. Metjian A, Roll RL, Ma AD, Abrams CS. 1999. Agonists cause nuclear translocation of phosphatidylinositol 3-kinase gamma. A Gbetagamma-dependent pathway that requires the p110gamma amino terminus. J Biol Chem 274: 27943-7.
106. Kumar A, Redondo-Munoz J, Perez-Garcia V, Cortes I, et al. 2011. Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival. Mol Cell Biol 31: 2122-33.
107. Zwaenepoel O, Tzenaki N, Vergetaki A, Makrigiannakis A, et al. 2012. Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110delta isoform of PI 3-kinase. FASEB J 26: 691-706.
108. Vanhaesebroeck B, Jones GE, Allen WE, Zicha D, et al. 1999. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol 1: 69-71.
109. Dhand R, Hiles I, Panayotou G, Roche S, et al. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13: 522-33.
110. Vanhaesebroeck B, Higashi K, Raven C, Welham M, et al. 1999. Autophosphorylation of p110δ phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J 18: 1292-302.
111. Czupalla C, Culo M, Muller EC, Brock C, et al. 2003. Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 278: 11536-45.
112. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, et al. 1998. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 282: 293-6.
113. Lam K, Carpenter CL, Ruderman NB, Friel JC, et al. 1994. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem 269: 20648-52.
114. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA. 2005. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat Cell Biol 7: 785-96.
115. Damilano F, Perino A, Hirsch E. 2010. PI3K kinase and scaffold functions in heart. Ann NY Acad Sci 1188: 39-45.
116. Bi L, Okabe I, Bernard DJ, Nussbaum RL. 2002. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm Genome 13: 169-72.
117. Perino A, Ghigo A, Ferrero E, Morello F, et al. 2011. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol Cell 42: 84-95.
118. Milne SB, Ivanova PT, DeCamp D, Hsueh RC, et al. 2005. A targeted mass spectrometric analysis of phosphatidylinositol phosphate species. J Lipid Res 46: 1796-802.
119. Wang YH, Collins A, Guo L, Smith-Dupont KB, et al. 2012. Divalent cation-induced cluster formation by polyphosphoinositides in model membranes. J Am Chem Soc 134: 3387-95.
120. Leopoldt D, Hanck T, Exner T, Maier U, et al. 1998. Gβgamma stimulates phosphoinositide 3-kinase-gamma by direct interaction with two domains of the catalytic p110 subunit. J Biol Chem 273: 7024-9.